Fatty acids and sterols are vital components of all eukaryotic cells. Both are used as building blocks for numerous cellular processes such as membrane biosynthesis or hormone production (sterols). Furthermore, these compounds elicit a variety of effects intracellularly as they can act as signalling molecules and regulate gene expression. The metabolism of fatty acids and sterols represents a very intricate network of pathways that are regulated in a precise manner in order to maintain lipid homoeostasis within a cell. Using the budding yeast Saccharomyces cerevisiae as a model system, we touch upon some of the aspects of achieving and maintaining this lipid homoeostasis.
Introduction
Lipid molecules (for example fatty acids and sterols) are vital components of all eukaryotic organisms. Fatty acids provide the cell with a concentrated energy source and serve as building blocks for numerous membrane lipids. Sterols are also an important constituent of eukaryotic cell membranes and in mammals act as precursors for steroid hormone and bile acid production. Both fatty acids and sterols have the capacity to act as signalling molecules and regulate gene expression via upstream promoter elements, such as OREs (oleate response elements) [1, 2] and SREs (sterol response elements) [3] . Furthermore, these molecules alter and maintain the fluidity of membranes and thus can be toxic to cells when present in excess.
Due to the inherent membrane perturbing properties of fatty acids and sterols, these compounds must be maintained at non-toxic levels within the cell. Some membranes seem to have a greater capacity (perhaps requirement?) for sterols, for example the plasma membrane versus the membranes of the ER (endoplasmic reticulum). Furthermore, nonesterified (free) fatty acids are so disruptive in terms of their detergent-like effects that they are absent from all membrane systems. And yet, both molecules must be available for the aforementioned positive roles they play in the cell. This exquisite homoeostasis is achieved through the concerted efforts of several regulatory pathways including synthesis, transport (both into and within the cells), neutralization and storage. The consequences of fatty acid and sterol imbalances due to a defect in any one of the previously mentioned regulatory events are great. In humans, deregulation of fatty acid and/or sterol levels leads to many disease states such as obesity, Type II diabetes, atherosclerosis and neurodegeneration. Therefore it is essential to gain a complete understandKey words: fatty acid, homoeostatic system, neutral lipid, sterol, steryl ester, triacylglycerol. Abbreviations used: ACAT, acyl-CoA:cholesterol acyltransferase; CLD, cytoplasmic lipid droplets; DG, diacylglycerol; DGAT2, diacylglycerol acyltransferase 2; ER, endoplasmic reticulum; LCAT, lecithin:cholesterol acyltransferase; SCD, stearoyl-CoA desaturase; SE, steryl ester; SRE, sterol response element; TG, triacylglycerol; WE, wax ester. 1 To whom correspondence should be addressed (email sls37@columbia.edu).
ing of the processes involved in fatty acid and sterol homoeostasis.
In this brief review, we touch upon some of the regulatory mechanisms involved in maintaining both fatty acid and sterol equilibrium within the cell. Using the yeast Saccharomyces cerevisiae as a model organism, we will describe how recent findings have helped to advance our understanding of fatty acids and sterol homoeostasis.
Fatty acids

Synthesis
Examination of the fatty acid profile in S. cerevisiae shows that the majority of endogenous saturated and mono-unsaturated fatty acids are 16 and 18 carbons in length [1] . De novo synthesis of saturated fatty acids in S. cerevisiae requires both acetyl-CoA carboxylase and the fatty acid synthase complex. The acetyl-CoA carboxylase is encoded by AAC1 (FAS3) [4, 5] . The fatty acid synthase complex comprises two subunits, α and β, organized as a hexamer (α 6 β 6 ), and are encoded by FAS2 [6] and FAS1 [7] respectively. Expression of these genes is repressed in the presence of fatty acids [8] , providing a means of regulation at the transcriptional level. Strains harbouring mutations in the fatty acid synthase complex cannot survive unless the medium is supplemented with myristic (C 14:0 ), palmitic (C 16:0 ), stearic (C 18:0 ) or oleic (C 18:1 ) acids [9] .
The synthesis of monounsaturated acids, namely palmitoleic (C 16:1 ) and oleic (C 18:1 ) acids, involves an additional desaturation step. This is achieved by the action of a 9 desaturase, Ole1p [10] . The OLE1 gene has sequence conservation with the human SCD (stearoyl-CoA desaturase) [11] and is probably equivalent in function since lesions in OLE1 can be functionally complemented by expression of rat SCD1 [12] . Transcription of OLE1 is induced, to some extent, by saturated fatty acids and is significantly repressed by unsaturated fatty acids [13, 14] . Furthermore, unsaturated fatty acids destabilize OLE1 mRNA transcripts [15] providing an additional means of regulation.
Uptake
Exogenous long-chain fatty acids can be taken up and readily incorporated into complex lipids; however, the mechanism by which fatty acids enter the cell is under debate. One model suggests that fatty acids passively diffuse through the plasma membrane in a 'flip-flop' type of mechanism that is independent of membrane-bound fatty acid transporters [16, 17] . In this scenario, transport is driven by fatty acid concentration gradients across the plasma membrane. Alternatively, a number of membrane-bound and membraneassociated proteins implicated in fatty acid transport have been identified in eukaryotic cells, including yeast proteins Faa1p, Faa4p and Fat1p [18] [19] [20] [21] . These proteins have been shown to concomitantly 'activate' fatty acids with an acylCoA group upon import, trapping them in the cytoplasm and further driving the system. This type of fatty acid transport has been termed 'vectorial acylation' [20] . The trapping of activated fatty acids to form pools is accomplished by the acyl-CoA-binding protein Acb1p; however, this protein does not have high affinity for non-esterified fatty acids [22] . Acb1p has been implicated in the trafficking of fatty acylCoA molecules within the cell as depletion of this gene leads to perturbations in sphingolipid synthesis and a reduction of very long-chain fatty acids [23, 24] .
Utilization
During times of glucose limitation, S. cerevisiae can utilize fatty acids as an energy source through β-oxidation. This process, which occurs predominantly in the mitochondria in mammals, takes place solely in the peroxisome of yeast. Medium-chain fatty acids first enter the peroxisome and become activated by the acyl-CoA synthetase Faa2p [25] . In contrast, long-chain and very long-chain fatty acids require activation with an acyl-CoA to transverse the peroxisomal membrane and enter β-oxidation. Long-chain fatty acyl-CoA import into the peroxisome is achieved through the actions of two ATP-binding cassette half-transporters, Pxa1p and Pxa2p [25] . It has been proposed that these proteins act to 'flip' the polar acyl-CoA group across the peroxisomal membrane; however, the mechanism of transport remains unclear [26] . Activated fatty acids in the peroxisomal lumen can then undergo a series of oxidation steps ultimately leading to the formation of NADH and acetyl-CoA. The responsible enzymes involved in this process are the gene products of POX1/FOX1, MFE2/FOX2, and POT1/FOX3 [27] .
Sterols
Synthesis
The predominant yeast sterol is ergosterol. Although this compound differs structurally from cholesterol, it is metabolized and utilized in processes that are physiologically similar. Under aerobic conditions, the acquisition of ergosterol is almost exclusively by means of biosynthesis. This process involves over 20 readily distinguishable reactions and is energetically expensive. The enzymes involved, such as the HMGCoA (3-hydroxy-3-methylglutaryl-CoA) reductases Hmg1p and Hmg2p, are well characterized at the molecular level [28, 29] . Ergosterol synthesis occurs primarily in the ER and is regulated both transcriptionally and post-translationally [30] ; however, the precise mechanisms of regulation are not well understood. Sterol biosynthesis is active under aerobic conditions, and, therefore, exogenous sterols are excluded from yeast cells in order to maintain sterol equilibrium. Ultimately, the control of this sterol exclusion is mediated predominantly by the actions of two transcription factors, Upc2p (uptake control) and Ecm22p, which recognize the conserved SREs found in many genes responsible for ergosterol metabolism [31] . The gene product of SUT1 has also been implicated in intracellular ergosterol regulation [32] .
Uptake
Because the synthesis of ergosterol requires oxygen, yeast must obtain sterols from the environment under anaerobic conditions. A genome-wide study in S. cerevisiae led to the identification of two genes involved in the uptake of free sterol from the environment: AUS1 and PDR11 [33] . These genes belong to the ATP-binding cassette transporter superfamily and are directly up-regulated by activation of the UPC2/ECM22 transcriptional cascade providing a coordination of sterol acquisition by uptake or synthesis. Interestingly, Aus1p and Pdr11p are currently the only two inward-directed sterol transporters belonging to the eukaryotic ABC transporter family.
Transport
In order to be effective, sterols must be transported from sites of biosynthesis (ER) or uptake (lysosomes) to sites of utilization [34] . There is an uneven distribution of free sterols within the endomembrane system suggesting that intracellular sterol trafficking is a very highly regulated process. It is proposed that there are three mechanisms for sterol transport: aqueous diffusion, vesicular transport and/or carrier proteins [35] . Several candidate sterol transporters have been identified in mammalian cell lines [36, 37] ; however, there are still many aspects that remain unclear.
Intracellular sterol transport is highly co-ordinated with sterol biosynthesis, uptake, utilization and storage. Therefore disruption of any one of these pathways would probably result in a compensatory alteration in one or more of the processes involved in sterol homoeostasis. Using this idea, our laboratory performed a genetic screen in order to identify putative yeast sterol transporters in the absence of sterol esterification using the ACAT (acyl-CoA:cholesterol acyltransferase)-related are1∆ are2∆ strains. The results from this screen identified ARV1 (ARE2 required for viability) that encodes a conserved, zinc-binding transmembrane protein.
The human homologue to yeast ARV1 (hARV1) is able to complement all of the known phenotypes, such as nystatinand temperature-sensitivity and anaerobic inviability [38] , of an arv1∆ mutant suggesting that this protein plays a conserved and comprehensive role in eukaryotic sterol metabolism. Arv1p is thought to be involved in anteriograde traffic of sterol and/or sphingolipids from the ER to the plasma membrane [38, 39] . The manner in which this protein directs the established gradient of sterol levels from the ER to the plasma membrane remains unclear; however, the consequences of its disruption are profound (A.L. Henneberry and S.L. Sturley, unpublished work). ARV1 deletions are deficient in many aspects of sterol and sphingolipid homoeostasis, including sterol uptake and complex sphingolipid biosynthesis and exhibit significant pleiotropy that extends beyond the known roles of lipids in the cell.
Fatty acid and sterol neutralization by co-esterification
Neutral lipid synthesis
Neutral lipids, such as TG (triacylglycerol) and SE (steryl ester) have low biological toxicity when compared with that of non-esterified fatty acids and free sterols providing an efficient and readily accessible sink for these biomolecules. TG is essentially formed by the addition of three fatty acid chains to a glycerol backbone. SE formation involves the addition of a fatty acid molecule to the oxygen group of ergosterol (or cholesterol). The neutral lipid synthetic machinery is strongly conserved throughout evolutionary history. The chief contributors to TG and SE biosynthesis belong to the ACAT, DGAT2 (diacylglycerol acyltransferase 2) and LCAT (lecithin:cholesterol acyltransferase) gene families (Table 1) . ACAT and DGAT2 members carry out the reaction in an acyl-CoA-dependent fashion, whereas LCAT relies on phospholipids as acyl donors.
In S. cerevisiae, the ACAT-related enzymes Are1p and Are2p are primarily responsible for the esterification of ergosterol and other sterols in yeast. However, these proteins do have detectable DG (diacylglycerol) esterification capabilities, particularly Are2p [40, 41] . Lro1p is the principal DG esterification enzyme during the exponential phase of growth, whereas the DGA1 gene product synthesizes TG during the stationary phase [42] . Cells lacking the ability to synthesize TG or SE or both do not show any apparent growth defects under normal conditions. However, Schizosaccharomyces pombe strains defective in TG synthesis display an increased sensitivity to exogenous fatty acids [43] .
TG and SE storage
Esterification of non-esterified fatty acids and free sterols occurs predominantly in the ER. There is a limited capacity to store these neutral lipids in the ER and therefore these compounds must be stored elsewhere in the cell. This is accomplished with the formation of discrete cytoplasmic particles called lipid droplets [CLD (cytoplasmic lipid droplets)]. These particles are made up of a phospholipid monolayer surrounding a hydrophobic core containing primarily TG and SE [44] . CLD formation is seen in all eukaryotes and Gram-positive strains of bacteria [45] . Although the exact mechanism of CLD formation is not known, a popular 'budding' hypothesis persists. Briefly, as increasing amounts of TG and SE are synthesized within the bilayer of the ER by the aforementioned enzymes, the outer leaflet begins to bulge outward. This eventually leads to separation or 'budding' away from the ER allowing the formation of an entirely distinct particle [44, 46] .
There is evidence to suggest that CLD are not just fat depots, but are very dynamic in nature. Isolation and analysis of these particles from both yeast and mammalian cells show that they have a complex protein profile and that protein inclusion/exclusion is a highly regulated process. Some of the proteins found associated with these droplets include those involved in lipid metabolism, cell signalling, and membrane trafficking [47, 48] . Furthermore, the protein profile of adipocyte CLD changes when the cellular environment changes, such as exposure to oleic acid [49] .
Summary
Fatty acids and sterols play essential roles in the homoeostasis of cells throughout all kingdoms of eukaryotic life. The importance of these molecules is shown in many aspects of lipid metabolism, including synthesis, transport, gene expression and storage. The disruption of any one or combination of these processes is seen in a number of diseases affecting our society, such as Type II diabetes, atherosclerosis, diabetes and certain neurodegenerative conditions. Therefore obtaining a more complete understanding of the mechanisms involving these compounds is imperative. Although much progress has been made in the elucidation of lipid metabolism in recent years, there are still many unanswered questions. The yeast S. cerevisiae, due to its homology to mammalian systems, completely sequenced genome, and ease of genetic manipulation, provides a valuable tool for studying these processes. We intend to continue our studies of S. cerevisiae mutants deficient in neutral lipid biosynthesis to define many aspects of lipid metabolism including how these cells cope with non-esterified fatty acid exposure.
Our research has been supported by the American Heart Association (National and Heritage), the Ara Parseghian Medical Research Foundation, the Hirschl/Weil-Caulier Trust and National Institutes of Health (DK54320). J.G. was supported by a predoctoral fellowship from the National Institutes of Health grant to R. Deckelbaum (Institute of Human Nutrition; DK07647-14). We thank the past and present members of our laboratory for their pivotal contributions to the studies presented here.
